We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPN
526
DELISTED
Superior Energy Services, Inc.
SPN
| $2.86M | 0.02% |
12,783
+9,882
| +341% | +$2.05M |
|
527
REX American Resources
REX
$1.41B
| $2.83M | 0.02% |
279,336
-751,614
| -73% | -$7.22M |
|
|
CXP
528
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.83M | 0.02% |
104,564
-23,200
| -18% | -$594K |
|
529
Huntington Ingalls Industries
HII
$12.8B
| $2.82M | 0.02% |
+20,100
| New | +$2.59M |
|
|
LHO
530
DELISTED
LaSalle Hotel Properties
LHO
| $2.8M | 0.02% |
72,050
+266
| +0.4% | +$10.7K |
|
531
CNA Financial
CNA
$14.1B
| $2.79M | 0.02% |
67,471
-291,660
| -81% | -$11.7M |
|
532
Graco
GGG
$13.5B
| $2.79M | 0.02% |
+116,100
| New | +$2.89M |
|
|
CALD
533
DELISTED
Callidus Software, Inc.
CALD
| $2.78M | 0.02% |
219,362
+56,846
| +35% | +$827K |
|
|
WBC
534
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.78M | 0.02% |
+22,588
| New | +$2.46M |
|
535
Provident Financial Services
PFS
$3.19B
| $2.77M | 0.02% |
148,571
-69,173
| -32% | -$1.25M |
|
536
InterDigital
IDCC
$8.89B
| $2.77M | 0.02% |
+54,601
| New | +$2.83M |
|
|
CSR
537
Centerspace
CSR
$952M
| $2.71M | 0.02% |
36,117
+15,626
| +76% | +$1.23M |
|
538
Omnicell
OMCL
$1.68B
| $2.71M | 0.02% |
77,163
-184,081
| -70% | -$6.07M |
|
|
PEI
539
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $2.69M | 0.02% |
7,713
-2,247
| -23% | -$799K |
|
|
NTRI
540
DELISTED
NutriSystem, Inc.
NTRI
| $2.68M | 0.02% |
134,188
+119,175
| +794% | +$2.21M |
|
|
EQC
541
DELISTED
Equity Commonwealth
EQC
| $2.68M | 0.02% |
100,905
-349,799
| -78% | -$9.19M |
|
|
IVC
542
DELISTED
Invacare Corporation
IVC
| $2.65M | 0.02% |
136,601
-49,706
| -27% | -$861K |
|
543
Piper Sandler
PIPR
$5.29B
| $2.65M | 0.02% |
201,828
-58,584
| -22% | -$796K |
|
|
LTM
544
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $2.61M | 0.02% |
324,300
+311,026
| +2,343% | +$3.17M |
|
545
International Bancshares
IBOC
$4.57B
| $2.61M | 0.02% |
100,130
+8,136
| +9% | +$200K |
|
546
Republic Services
RSG
$65.7B
| $2.6M | 0.02% |
64,223
+33,170
| +107% | +$1.35M |
|
547
Amdocs
DOX
$6.22B
| $2.6M | 0.02% |
47,816
-165,404
| -78% | -$8.34M |
|
548
Lifecore Biomedical
LFCR
$190M
| $2.6M | 0.02% |
186,431
-40,326
| -18% | -$557K |
|
|
MTOR
549
DELISTED
MERITOR, Inc.
MTOR
| $2.59M | 0.02% |
205,666
-96,387
| -32% | -$1.34M |
|
550
Civeo
CVEO
$318M
| $2.59M | 0.02% |
84,979
+11,910
| +16% | +$466K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.